ORIC PHARMACEUTICALS, INC. Interest Income, Other
ORIC PHARMACEUTICALS, INC. (ORIC) reported Interest Income, Other of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2022-11-07
- ORIC PHARMACEUTICALS, INC. interest income, other for the quarter ending 2022-09-30 was $0.00.
- ORIC PHARMACEUTICALS, INC. interest income, other for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- ORIC PHARMACEUTICALS, INC. interest income, other for the quarter ending 2021-09-30 was $0.00.
- ORIC PHARMACEUTICALS, INC. interest income, other for the quarter ending 2021-06-30 was $15.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $15.00K derived: sum of 2 quarters · filed 2022-11-07 | $15.00K 10-Q · filed 2022-11-07 |
| 2021-06-30 | $15.00K 10-Q · filed 2022-08-11 | $15.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |